Jivi 1000 Unit (Antihemophilic Factor (Recombinant, B-Domain Deleted, Pegylated) POWDER FOR SOLUTION) 1000 UNIT

JIVI 1000 Unit is a recombinant antihemophilic factor used for hemophilia B treatment. This intravenous powder for solution helps manage bleeding episodes and prevent surgical bleeding.

Strength

1000 UNIT

Manufacturer / TM Owner

BAYER INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

JIVI 1000 Unit is primarily used to control and prevent bleeding in patients with hemophilia B, a condition characterized by a deficiency in clotting factor IX. It is administered intravenously to replace the missing clotting factor, aiding in blood coagulation. This medication is often used during surgical procedures to minimize blood loss and can be part of a routine prophylaxis regimen to prevent bleeding episodes.

Side Effects

Common effects of JIVI 1000 Unit may include localized reactions at the injection site, such as redness or swelling. Some users might experience mild flu-like symptoms, including headache or fatigue. These effects are generally temporary and resolve on their own. Severe reactions are rare but should be reported to a healthcare provider immediately.

Precautions & Warnings

JIVI 1000 Unit should be handled with care, ensuring proper storage and preparation. It is essential to follow the prescribed administration guidelines to minimize the risk of adverse reactions. Patients with known allergies to any components of the medication should avoid its use. Always consult a healthcare provider before starting or adjusting any treatment regimen.

Avoid Interactions

JIVI 1000 Unit may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods might also influence the effectiveness of this medication, so it is advisable to discuss dietary and lifestyle factors with a healthcare professional.

Frequently Asked Questions

JIVI 1000 Unit is used to control and prevent bleeding in patients with hemophilia B.

JIVI 1000 Unit is administered intravenously as a powder for solution.

Common side effects may include localized reactions at the injection site and mild flu-like symptoms.

Yes, JIVI 1000 Unit is often used during surgical procedures to minimize blood loss.

Long-term use should be monitored by a healthcare provider to ensure safety and effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.